Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Vertical Transmission of COVID-19: A Systematic Review.
Fathi Najafi, T; Dashti, S; Bahri, N;
2020
ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, (2020).In Pre In Pre 10.5812/pedinfect.101087.
Broad cross-national public support for accelerated COVID-19 vaccine trial designs.
Broockman, D; Kalla, J; Guerrero, A; Budolfson, M; Eyal, N; JEWELL, NP; Magalhaes, M; Sekhon, JS;
2020
Vaccine, (2020).39 2 10.1016/j.vaccine.2020.11.072.
Acceptability and feasibility of strategies to shield the vulnerable during the COVID-19 outbreak: a qualitative study in six Sudanese communities.
ABDELMAGID, N; Ahmed, SA E; Nurelhuda, N; Zainalabdeen, I; Ahmed, A; Fadlallah, MA; DAHAB, M;
2020
(2020). 10.1101/2020.12.14.20248160.
Are commercial antibody assays substantially underestimating SARS-CoV-2 ever infection? An analysis on a population-based sample in a high exposure setting.
Nasrallah, GK; Dargham, SR; Shurrab, F; Al-Sadeq, DW; Al-Jighefee, H; CHEMAITELLY, H; Kanaani, ZA; Khal, AA; Kuwari, EA; Coyle, P; Jeremijenko, A; Kaleeckal, AH; Latif, AN; Shaik, RM; Abdul Rahim, HF; Yassine, HM; Al Kuwari, MG; Qotba, H; Romaihi, HE A; Tang, P; Bertollini, R; Al-Thani, M; Althani, AA; Abu-Raddad, LJ;
2020
medRxiv preprint (2020). 10.1101/2020.12.14.20248163.
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
Abu-Raddad, LJ; CHEMAITELLY, H; Malek, JA; Ahmed, AA; Mohamoud, YA; Younuskunju, S; Ayoub, HH; Al Kanaani, Z; Al Khal, A; Al Kuwari, E; Butt, AA; Coyle, P; Jeremijenko, A; Kaleeckal, AH; Latif, AN; Shaik, RM; Abdul Rahim, HF; Yassine, HM; Al Kuwari, MG; Al Romaihi, HE; Al-Thani, MH; Bertollini, R;
2020
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2020).73 7 10.1093/cid/ciaa1846.
Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation analysis.
Kiang, MV; Chin, ET; Huynh, BQ; CHAPMAN, LA C; Rodríguez-Barraquer, I; Greenhouse, B; Rutherford, GW; Bibbins-Domingo, K; Havlir, D; Basu, S; Lo, NC;
2020
openRxiv (2020). 10.1101/2020.12.08.20246132.
Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality: a nationwide cohort study of hospitalized patients in the United States.
RENTSCH, CT; Beckman, JA; TOMLINSON, L; Gellad, WF; Alcorn, C; Kidwai-Khan, F; Skanderson, M; Brittain, E; King, JT; Ho, Y-L; Eden, S; Kundu, S; Lann, MF; Greevy, RA; Ho, PM; Heidenreich, PA; Jacobson, DA; DOUGLAS, IJ; Tate, JP; EVANS, SJ; Atkins, D; Justice, AC; Freiberg, MS;
2020
medRxiv (2020). 10.1101/2020.12.09.20246579.
HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform.
BHASKARAN, K; RENTSCH, CT; MacKenna, B; SCHULTZE, A; Mehrkar, A; Bates, CJ; EGGO, RM; Morton, CE; Bacon, SC J; Inglesby, P; Doughlas, IJ; Walker, AJ; MCDONALD, H; Cockburn, J; WILLIAMSON, EJ; Evans, D; FORBES, HJ; Curtis, HJ; Hulme, WJ; Parry, J; Hester, F; Harper, S; EVANS, SJ W; SMEETH, L; GOLDACRE, B;
2020
LANCET HIV, (2020).8 1 10.1016/S2352-3018(20)30305-2.
Covid-19 mass testing: throwing the baby out with the bathwater?.
PETO, J; Hunter, DJ; Riboli, E;
2020
BMJ-BRITISH MEDICAL JOURNAL, (2020).371, 10.1136/bmj.m4782.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Voysey, M; Clemens, SA C; Madhi, SA; Weckx, LY; Folegatti, PM; Aley, PK; Angus, B; Baillie, VL; Barnabas, SL; Bhorat, QE; Bibi, S; Briner, C; Cicconi, P; Collins, AM; Colin-Jones, R; Cutland, CL; Darton, TC; DHEDA, K; Duncan, CJ A; Emary, KR W; Ewer, KJ; Fairlie, L; Faust, SN; Feng, S; Ferreira, DM; ... Oxford COVID Vaccine Trial Group,
2020
Lancet (London, England), (2020).397 10269 10.1016/s0140-6736(20)32661-1.